• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Aliment Pharmacol Ther . The association between markers of liver injury and clinical outcomes in patients with COVID-19 in Wuhan

tetano

Editor, Senior Moderator
Aliment Pharmacol Ther


. 2020 Jul 22.
doi: 10.1111/apt.15962. Online ahead of print.
The association between markers of liver injury and clinical outcomes in patients with COVID-19 in Wuhan


Haijun Huang[SUP] 1 [/SUP], Shanshan Chen[SUP] 1 2 [/SUP], Hong Li[SUP] 1 3 [/SUP], Xian-Long Zhou[SUP] 4 [/SUP], Yining Dai[SUP] 1 [/SUP], Wu Jia[SUP] 1 [/SUP], Jun Zhang[SUP] 1 [/SUP], Lina Shao[SUP] 1 [/SUP], Rong Yan[SUP] 1 [/SUP], Mingshan Wang[SUP] 1 [/SUP], Jiafeng Wang[SUP] 1 [/SUP], Yuexing Tu[SUP] 1 [/SUP], Minghua Ge[SUP] 1 [/SUP]



Affiliations

Abstract

Background: The outbreak of coronavirus disease 2019 (COVID-19) is a critical challenge for public health. The effect of COVID-19 on liver injury has not been fully presented.
Aims: To evaluate the dynamic changes in liver function and the relationship between liver function damage and prognosis in patients with COVID-19.
Methods: Retrospective analysis of clinical data of 675 patients with COVID-19 in Zhongnan Hospital of Wuhan University from January 3 to March 8, 2020. Patients were classified as normal, abnormal liver function and liver injury.
Results: Of 675 patients, 253 (37.5%) had abnormal liver function during hospitalisation, and 52 (7.7%) had liver injury. The dynamic changes of ALT and AST levels were more significant in patients with liver injury and in those who died. AST >3-fold ULN had the highest risk of death and mechanical ventilation. Compared to patients with normal AST levels, mortality and risk of mechanical ventilation significantly increased 19.27-fold (95% confidence interval [CI], 4.89-75.97; P < 0.0001) and 116.72-fold (95% CI, 31.58-431.46; P < 0.0001), respectively, in patients with AST above 3-fold ULN. Increased leucocytes, decreased lymphocytes and female sex were independently associated with liver injury.
Conclusions: The dynamic changes in liver function may have a significant correlation with the severity and prognosis of COVID-19. Increased index of liver injury was closely related to mortality and need for mechanical ventilation. Therefore, these indicators should be closely monitored during hospitalisation.
 
Back
Top Bottom